Coronary artery disease trials in Kazakhstan

1 trial · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  Study to Assess Safety and Efficacy of Treating Symptomatic, Ischemic, Chronic Congestive Heart Failure Patients with an LVEF of ≤40% with Fresh, Uncultured, Autologous, Adipose-derived Regenerative Cells Isolated from Lipoaspirate.

  Where

  Astana

  Age

  21 years to 80 years

  People

  36

  Run by

  Ralf Rothoerl

  See details and how to joinNCT06705023